0001104659-21-153334.txt : 20211223
0001104659-21-153334.hdr.sgml : 20211223
20211223214321
ACCESSION NUMBER: 0001104659-21-153334
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211222
FILED AS OF DATE: 20211223
DATE AS OF CHANGE: 20211223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fattori Ruth A
CENTRAL INDEX KEY: 0001306826
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39949
FILM NUMBER: 211518756
MAIL ADDRESS:
STREET 1: 1303 EAST ALGONQUIN ROAD
CITY: SCHAUMBURG
STATE: IL
ZIP: 60196
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hyperfine, Inc.
CENTRAL INDEX KEY: 0001833769
STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 351 NEW WHITFIELD STREET
CITY: GUILFORD
STATE: CT
ZIP: 06437
BUSINESS PHONE: 866-796-6767
MAIL ADDRESS:
STREET 1: 351 NEW WHITFIELD STREET
CITY: GUILFORD
STATE: CT
ZIP: 06437
FORMER COMPANY:
FORMER CONFORMED NAME: HealthCor Catalio Acquisition Corp.
DATE OF NAME CHANGE: 20201124
4
1
tm2135698-18_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-22
0
0001833769
Hyperfine, Inc.
HYPR
0001306826
Fattori Ruth A
C/O HYPERFINE, INC.
530 OLD WHITFIELD STREET
GUILFORD
CT
06437
1
0
0
0
Class A Common Stock
2021-12-22
4
A
0
891
A
891
D
Class A Common Stock
2021-12-23
4
A
0
16483
0.00
A
17374
D
In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Optimus Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub I"), Optimus Merger Sub II, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub II"), Hyperfine, Inc., a Delaware corporation ("Hyperfine"), and Liminal Sciences, Inc., a Delaware corporation ("Liminal"), pursuant to which
Merger Sub I merged with and into Hyperfine (the "Hyperfine Merger"), with Hyperfine surviving the Hyperfine Merger as a wholly owned subsidiary of HealthCor, and Merger Sub II merged with and into Liminal (the "Liminal Merger" and, together with the Hyperfine Merger, the "Mergers"), with Liminal surviving the Liminal Merger as a wholly owned subsidiary of HealthCor (which changed its name to "Hyperfine, Inc.", the "Issuer"), these shares were received in exchange for 4,962 shares of Liminal Series A-2 preferred stock.
Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on December 23, 2022, subject to Ms. Fattori's continued service through the applicable vesting date.
/s/ John P. Condon, Attorney-in-Fact
2021-12-23